Back

Coronary sinus reducer device for the treatment of refractory angina: a single center experience

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Acute and chronic coronary syndromes Nonpharmacological Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Miguel Sobral Domingues

Western Lisbon Hospital Centre, EPE, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Methylome of circulating cell free DNA as a novel biomarker tool: from acute coronary syndrome to broader risk stratification of cardiovascular disease
Doctor A. Kratzer (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
How to predict myocardial injury in patients with large ischaemic burden identified during stress echocardiography?
Doctor K. Vakalis (Harefield, Uxbridge, GB)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of Shexiang Baoxin pill in patients with ischemia with non-obstructive coronary arteries (LESS): a phase 4, multicenter, randomized, double-blind, placebo-controlled clinical trial
Professor N. Li (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Longitudinal and cross-sectional associations of NT-proBNP with kidney function and chronic kidney disease: results from KORA cohort studies
Mr J. Lin (Neuherberg, DE)
Abstract Slides Video
Presentation thumbnail
Symptomatic patients without coronary artery disease do not have excess cardiovascular risk compared to the general population
Doctor K. Olesen (Aarhus, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Acute and chronic coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Clinical observations on the use of the coronary sinus reducer for managing refractory angina pectoris: Insights from a single center case series
thumbnail
Congress Presentation
Treatment of microvascular angina with the coronary sinus reducer: a first experience
thumbnail
Congress Presentation
The use of the coronary sinus reducer for treating patients with refractory angina and diabetes mellitus: one-year outcomes from the REDUCER-I registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources